Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBio-Techne Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 9 | $0.50 | $0.57 | $0.54 |
| Q2 2026 | 9 | $0.54 | $0.59 | $0.56 |
| Q3 2026 | 3 | $0.44 | $0.47 | $0.46 |
| Q4 2026 | 7 | $0.49 | $0.52 | $0.51 |
| Q1 2027 | 3 | $0.58 | $0.61 | $0.59 |
| Q2 2027 | 3 | $0.61 | $0.64 | $0.63 |
| Q3 2027 | 4 | $0.49 | $0.52 | $0.50 |
| Q4 2027 | 3 | $0.54 | $0.58 | $0.56 |
| Q1 2028 | 4 | $0.63 | $0.66 | $0.65 |
| Q2 2028 | 4 | $0.65 | $0.69 | $0.67 |
Bio-Techne Corp Earnings Date And Information
Bio-Techne Corp last posted its earnings results on Wednesday, February 4th, 2026. The company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. The company had revenue of 295.88 M for the quarter and had revenue of 1.22 B for the year. Bio-Techne Corp has generated $0 earnings per share over the last year ($0.46 diluted earnings per share) and currently has a price-to-earnings ratio of 114. Bio-Techne Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Bio-Techne Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q2 2026 | $0.43 | $0.24 | -0.19 | $290.47 M | $295.88 M |
| 11/05/2025 | Q1 2026 | $0.42 | $0.25 | -0.17 | $291.32 M | $286.56 M |
| 08/22/2025 | Q4 2025 | N/A | -$0.11 | N/A | $314.61 M | $316.96 M |
| 05/08/2025 | Q3 2025 | N/A | $0.14 | N/A | $317.19 M | $316.18 M |
| 02/06/2025 | Q2 2025 | N/A | $0.22 | N/A | $285.78 M | $297.03 M |
| 11/05/2024 | Q1 2025 | N/A | $0.21 | N/A | $280.22 M | $289.46 M |
| 08/22/2024 | Q4 2024 | N/A | $0.26 | N/A | $306.49 M | $306.10 M |
| 05/06/2024 | Q3 2024 | N/A | $0.31 | N/A | $292.15 M | $303.43 M |
| 02/07/2024 | Q2 2024 | N/A | $0.17 | N/A | N/A | $272.60 M |
| 11/07/2023 | Q1 2024 | N/A | $0.32 | N/A | N/A | $276.94 M |
| 08/23/2023 | Q4 2023 | N/A | $0.48 | N/A | N/A | $301.32 M |
| 05/08/2023 | Q3 2023 | N/A | $0.45 | N/A | N/A | $294.15 M |
| 02/07/2023 | Q2 2023 | N/A | $0.32 | N/A | N/A | $271.58 M |
| 11/07/2022 | Q1 2023 | N/A | $0.57 | N/A | N/A | $269.66 M |
| 08/24/2022 | Q4 2022 | N/A | $0.39 | N/A | N/A | $288.23 M |
| 05/09/2022 | Q3 2022 | N/A | $0.39 | N/A | N/A | $290.38 M |
| 02/07/2022 | Q2 2022 | N/A | $0.51 | N/A | N/A | $269.28 M |
| 11/08/2021 | Q1 2022 | N/A | $0.45 | N/A | N/A | $257.72 M |
| 08/25/2021 | Q4 2021 | N/A | $0.10 | N/A | N/A | $259.03 M |
| 05/07/2021 | Q3 2021 | N/A | $0.29 | N/A | N/A | $243.55 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bio-Techne Corp Earnings: FAQ's
In the previous quarter, Bio-Techne Corp (:TECH) reported $0.46 earnings per share (EPS) to beat the analysts' consensus estimate of $0.43 by $0.03.
The conference call for Bio-Techne Corp's latest earnings report can be listened to online.
The conference call transcript for Bio-Techne Corp's latest earnings report can be read online.
Bio-Techne Corp (:TECH) has a recorded annual revenue of $1.22 B.
Bio-Techne Corp (:TECH) has a recorded net income of $73.40 M.Bio-Techne Corp has generated $0.47 earnings per share over the last four quarters.
Bio-Techne Corp (:TECH) has a price-to-earnings ratio of 114 and price/earnings-to-growth ratio is 28.5.